FDA approves dupilumab for chronic rhinosinusitis with nasal polyps FDA, 비용종을 동반한 만성 비부비동염에 두필루맙 승인
FDA approves dupilumab for chronic rhinosinusitis with nasal polyps Reuters (6/26, Mathias, Mishra) reports that on June 26, the Food and Drug Administration “approved Regeneron Pharmaceuticals Inc and Sanofi SA’s drug Dupixent [dupilumab] to treat nasal polyps.” The injectable … Continued